Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer

Renal cancer ranks twelfth in incidence among cancers worldwide. Despite improving outcomes due to better therapeutic options and strategies, prognosis for those with metastatic disease remains poor. Current systemic therapeutic approaches include inhibiting pathways of angiogenesis, immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihalopoulos, Meredith, Dovey, Zachary, Archer, Maddison, Korn, Talia G., Okhawere, Kennedy E., Nkemdirim, William, Funchess, Hassan, Rambhia, Ami, Mohamed, Nihal, Kaplan, Steven A., Mehrazin, Reza, Lundon, Dara, Tsao, Che-Kai, Badani, Ketan K., Kyprianou, Natasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564811/
https://www.ncbi.nlm.nih.gov/pubmed/32872127
http://dx.doi.org/10.3390/cancers12092442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564811/
https://www.ncbi.nlm.nih.gov/pubmed/32872127
http://dx.doi.org/10.3390/cancers12092442

Ejemplares similares